Concepts (61)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Embolism, Amniotic Fluid | 1 | 2012 | 2 | 0.360 |
Why?
|
| Adenosine | 4 | 2004 | 74 | 0.320 |
Why?
|
| Capsaicin | 3 | 2003 | 32 | 0.260 |
Why?
|
| Analgesics, Opioid | 3 | 2004 | 265 | 0.250 |
Why?
|
| Hyperalgesia | 3 | 2003 | 86 | 0.250 |
Why?
|
| Piperidines | 2 | 2004 | 141 | 0.240 |
Why?
|
| Pain | 3 | 2002 | 330 | 0.230 |
Why?
|
| Amides | 1 | 2004 | 30 | 0.210 |
Why?
|
| Central Nervous System Diseases | 1 | 2004 | 18 | 0.210 |
Why?
|
| Anesthesia, Conduction | 1 | 2004 | 27 | 0.210 |
Why?
|
| Bupivacaine | 1 | 2004 | 60 | 0.200 |
Why?
|
| Anesthetics, Local | 1 | 2004 | 96 | 0.200 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2002 | 16 | 0.190 |
Why?
|
| Adult | 9 | 2012 | 10015 | 0.120 |
Why?
|
| Injections, Spinal | 6 | 2004 | 124 | 0.100 |
Why?
|
| Fentanyl | 2 | 2004 | 37 | 0.100 |
Why?
|
| Morphine | 2 | 2004 | 54 | 0.100 |
Why?
|
| Blood Substitutes | 1 | 2012 | 2 | 0.090 |
Why?
|
| Survival | 1 | 2012 | 14 | 0.090 |
Why?
|
| Apgar Score | 1 | 2012 | 10 | 0.090 |
Why?
|
| Blood Coagulation Tests | 1 | 2012 | 10 | 0.090 |
Why?
|
| Plasma | 1 | 2012 | 15 | 0.090 |
Why?
|
| Erythrocyte Transfusion | 1 | 2012 | 35 | 0.090 |
Why?
|
| Blood Loss, Surgical | 1 | 2012 | 55 | 0.090 |
Why?
|
| Shock | 1 | 2012 | 34 | 0.090 |
Why?
|
| Pain Measurement | 2 | 2003 | 385 | 0.090 |
Why?
|
| Male | 9 | 2012 | 20697 | 0.090 |
Why?
|
| Seizures | 1 | 2012 | 67 | 0.090 |
Why?
|
| Resuscitation | 1 | 2012 | 69 | 0.090 |
Why?
|
| Analgesia, Obstetrical | 1 | 2012 | 55 | 0.090 |
Why?
|
| Female | 9 | 2012 | 21490 | 0.090 |
Why?
|
| Analgesics | 2 | 2002 | 117 | 0.080 |
Why?
|
| Hemodynamics | 1 | 2012 | 168 | 0.080 |
Why?
|
| Cesarean Section | 1 | 2012 | 122 | 0.080 |
Why?
|
| Diagnosis, Differential | 1 | 2012 | 540 | 0.080 |
Why?
|
| Infant, Newborn | 1 | 2012 | 730 | 0.080 |
Why?
|
| Ultrasonography | 1 | 2012 | 417 | 0.080 |
Why?
|
| Pregnancy | 1 | 2012 | 1069 | 0.070 |
Why?
|
| Pain Threshold | 3 | 2004 | 105 | 0.070 |
Why?
|
| Humans | 9 | 2012 | 34474 | 0.070 |
Why?
|
| Double-Blind Method | 3 | 2002 | 597 | 0.060 |
Why?
|
| Infusions, Intravenous | 2 | 2004 | 110 | 0.060 |
Why?
|
| Middle Aged | 6 | 2004 | 12703 | 0.050 |
Why?
|
| Oxyhemoglobins | 1 | 2003 | 9 | 0.050 |
Why?
|
| Heart Rate | 2 | 2002 | 372 | 0.050 |
Why?
|
| Nausea | 1 | 2003 | 55 | 0.050 |
Why?
|
| Spinal Cord | 1 | 2004 | 150 | 0.050 |
Why?
|
| Aminophylline | 1 | 2002 | 8 | 0.050 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2002 | 17 | 0.050 |
Why?
|
| Ketorolac | 1 | 2002 | 25 | 0.050 |
Why?
|
| Hypersensitivity | 1 | 2002 | 26 | 0.050 |
Why?
|
| Hot Temperature | 1 | 2002 | 89 | 0.050 |
Why?
|
| Administration, Topical | 1 | 2002 | 146 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 755 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2002 | 901 | 0.030 |
Why?
|
| Adolescent | 3 | 2004 | 3799 | 0.020 |
Why?
|
| Back Pain | 1 | 2002 | 32 | 0.010 |
Why?
|
| Leg | 1 | 2002 | 71 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2002 | 508 | 0.010 |
Why?
|
| Time Factors | 1 | 2004 | 2352 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2003 | 1386 | 0.010 |
Why?
|